Celularity (CELU) EBT Margin (2020 - 2026)
Celularity's EBT Margin came in at -593.54% for Q4 2025, down 520.23 percentage points from -73.31% a year earlier and down 156.83 percentage points from the prior quarter.
Powered by 
Analysis
Celularity (CELU) EBT Margin (2020 - 2026) Analysis & Trends
For FY2025, Celularity's EBT Margin was -345.44%, down 238.66 percentage points from FY2024.
- EBT Margin carries a five-year change of +1145.90 percentage points (FY2020 to FY2025).
- Going back by year, EBT Margin was -106.77% in FY2024 (+755.22 pp), -862.00% in FY2023 (-941.02 pp), 79.03% in FY2022 (+548.20 pp) and -469.17% in FY2021 (+1022.16 pp).
- The Q4 2025 figure represents the lowest quarterly EBT Margin since Q3 2023.
- Year-over-year, EBT Margin has declined for five consecutive quarters, with an average year-over-year change of +503.61 percentage points over the last eight quarters.
- The fastest year-over-year change in EBT Margin over five years came in Q2 2022 (a gain of 3283.83 percentage points), and the weakest in Q2 2023 (a drop of 2899.06 percentage points).
- Business Quant data shows CELU's EBT Margin at -436.71% (Q3 2025), -427.55% (Q2 2025) and -172.89% (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 41.75% |
| 10 | Celularity | 39.39 Mn | 31.87 Mn | 2.39 Mn | -271.01% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -271.01% |
| Dec 31, 2025 | -593.54% |
| Sep 30, 2025 | -436.71% |
| Jun 30, 2025 | -427.55% |
| Mar 31, 2025 | -172.89% |
| Dec 31, 2024 | -73.31% |
| Sep 30, 2024 | -173.17% |
| Jun 30, 2024 | -53.57% |
| Mar 31, 2024 | -149.94% |
| Dec 31, 2023 | 78.91% |
| Sep 30, 2023 | -2,479.56% |
| Jun 30, 2023 | -1,632.03% |
| Mar 31, 2023 | -1,626.86% |
| Dec 31, 2022 | 592.08% |
| Sep 30, 2022 | 115.65% |
| Jun 30, 2022 | 1,267.03% |
| Mar 31, 2022 | -1,059.26% |
| Dec 31, 2021 | -82.78% |
| Sep 30, 2021 | 470.14% |
| Jun 30, 2021 | -2,016.80% |
API Access
Celularity EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=CELU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "CELU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=CELU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();